• 1
    Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003; 3: 653661.
  • 2
    Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010; 23: 412441.
  • 3
    Kim YK, Lee SC, Kim C, Heo ST, Choi C, Kim JM. Clinical and laboratory predictors of oliguric renal failure in haemorrhagic fever with renal syndrome caused by Hantaan virus. J Infect 2007; 54: 381386.
  • 4
    Libraty DH, Makela S, Vlk J et al. The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemica. PLoS ONE 2012; 7: e35402.
  • 5
    Dolgin E. Hantavirus treatments advance amidst outbreak in US park. Nat Med 2012; 18: 1448.
  • 6
    Rusnak JM, Byrne WR, Chung KN et al. Experience with intravenous Ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res 2009; 81: 6876.
  • 7
    Korva M, Saksida A, Kunilo S, Vidan Jeras B, Avsic-Zupanc T. HLA-associated hemorrhagic fever with renal syndrome disease progression in Slovenian patients. Clin Vaccine Immunol 2011; 18: 14351440.
  • 8
    Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009; 102: 10301041.
  • 9
    Björkström NK, Lindgren T, Stoltz M et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011; 208: 1321.
  • 10
    Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK. Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 2011; 85: 1025210260.
  • 11
    Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, Schnitzler P. Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 2011; 12: 65.
  • 12
    Saksida A, Wraber B, Avsic-Zupanc T. Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis 2011; 11: 142.
  • 13
    Saksida A, Duh D, Korva M, Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008; 197: 681685.
  • 14
    Terajima M, Hendershot JD 3rd, Kariwa H et al. High levels of viremia in patients with the hantavirus pulmonary syndrome. J Infect Dis 1999; 180: 20302034.
  • 15
    Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B. Sin nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006; 194: 14031409.
  • 16
    Yi J, Xu Z, Zhuang R et al. Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis 2012; 207: 14571461.
  • 17
    Huggins JW, Hsiang CM, Cosgriff TM et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164: 11191127.
  • 18
    Mertz GJ, Miedzinski L, Goade D et al. Placebo-controlled, double-blind trial of intravenous Ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004; 39: 13071313.
  • 19
    Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000; 182: 4348.
  • 20
    MacNeil A, Comer JA, Ksiazek TG, Rollin PE. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J Infect Dis 2010; 202: 242246.
  • 21
    de Carvalho Nicacio C, Bjorling E, Lundkvist A. Immunoglobulin A responses to Puumala hantavirus. J Gen Virol 2000; 81: 14531461.
  • 22
    Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet 1991; 338: 13531356.
  • 23
    Sundberg E, Hultdin J, Nilsson S, Ahlm C. Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS ONE 2011; 6: e21134.
  • 24
    Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007; 45: 24912497.
  • 25
    Pettersson L, Rasmuson J, Andersson C, Ahlm C, Evander M. Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome. J Med Virol 2011; 83: 864870.
  • 26
    Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis 2010; 16: 15841586.
  • 27
    Klein SL, Marks MA, Li W et al. Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004–2008. Clin Infect Dis 2011; 52: 14141421.
  • 28
    Rasmuson J, Pourazar J, Linderholm M, Sandstrom T, Blomberg A, Ahlm C. Presence of activated airway T lymphocytes in human Puumala hantavirus disease. Chest 2011; 140: 715722.
  • 29
    Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS ONE 2012; 7: e35996.
  • 30
    Klingström J, Stoltz M, Hardestam J, Ahlm C, Lundkvist A. Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge. Antivir Ther 2008; 13: 125133.